PDB Short entry for 5AP4 HEADER TRANSFERASE 14-SEP-15 5AP4 TITLE NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO TITLE 2 KINASE INHIBITOR DRUG RESISTANCE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE TTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 519-808; COMPND 5 SYNONYM: PHOSPHOTYROSINE PICKED THREONINE-PROTEIN KINASE, PYT, COMPND 6 MONOPOLAR SPINDLE KINASE 1; COMPND 7 EC: 2.7.12.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: AI KEYWDS TRANSFERASE, MPS1, PROTEIN KINASE, MITOSIS, DRUG RESISTANCE EXPDTA X-RAY DIFFRACTION AUTHOR M.D.GURDEN,I.M.WESTWOOD,A.FAISAL,S.NAUD,K.J.CHEUNG,C.MCANDREW,A.WOOD, AUTHOR 2 J.SCHMITT,K.BOXALL,G.MAK,P.WORKMAN,R.BURKE,S.HOELDER,J.BLAGG, AUTHOR 3 R.L.M.VAN MONTFORT,S.LINARDOPOULOS REVDAT 2 10-JAN-24 5AP4 1 REMARK LINK REVDAT 1 23-SEP-15 5AP4 0 JRNL AUTH M.D.GURDEN,I.M.WESTWOOD,A.FAISAL,S.NAUD,K.J.CHEUNG, JRNL AUTH 2 C.MCANDREW,A.WOOD,J.SCHMITT,K.BOXALL,G.MAK,P.WORKMAN, JRNL AUTH 3 R.BURKE,S.HOELDER,J.BLAGG,R.L.M.VAN MONTFORT,S.LINARDOPOULOS JRNL TITL NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE JRNL TITL 2 CELLS TO KINASE INHIBITOR DRUG RESISTANCE. JRNL REF CANCER RES. V. 75 3340 2015 JRNL REFN ISSN 0008-5472 JRNL PMID 26202014 JRNL DOI 10.1158/0008-5472.CAN-14-3272 REMARK 2 REMARK 2 RESOLUTION. 2.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.86 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 10480 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.820 REMARK 3 FREE R VALUE TEST SET COUNT : 505 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.85 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.55 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2869 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2244 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2731 REMARK 3 BIN R VALUE (WORKING SET) : 0.2229 REMARK 3 BIN FREE R VALUE : 0.2548 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.81 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 138 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2007 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 20 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 96.46 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 84.06 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 11.99200 REMARK 3 B22 (A**2) : 2.50300 REMARK 3 B33 (A**2) : -14.49500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.401 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.567 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.287 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.562 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.291 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2117 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2863 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 715 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 51 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 317 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2117 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 278 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2436 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.19 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.73 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.82 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|515 - 544} REMARK 3 ORIGIN FOR THE GROUP (A): 9.7408 -7.5499 -19.0324 REMARK 3 T TENSOR REMARK 3 T11: -0.2260 T22: -0.2556 REMARK 3 T33: 0.2882 T12: -0.0035 REMARK 3 T13: 0.0649 T23: -0.1520 REMARK 3 L TENSOR REMARK 3 L11: 8.0913 L22: 4.4904 REMARK 3 L33: 4.9044 L12: 0.9424 REMARK 3 L13: -2.9104 L23: 2.9104 REMARK 3 S TENSOR REMARK 3 S11: -0.0536 S12: -0.5442 S13: 0.3616 REMARK 3 S21: 0.1154 S22: 0.0482 S23: -0.3049 REMARK 3 S31: -0.2110 S32: 0.3432 S33: 0.0054 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: {A|545 - 662} REMARK 3 ORIGIN FOR THE GROUP (A): -0.9986 -19.3925 -21.6647 REMARK 3 T TENSOR REMARK 3 T11: -0.1475 T22: -0.1166 REMARK 3 T33: 0.0381 T12: 0.0528 REMARK 3 T13: -0.0425 T23: -0.0451 REMARK 3 L TENSOR REMARK 3 L11: 5.3800 L22: 2.6409 REMARK 3 L33: 1.4520 L12: 1.4797 REMARK 3 L13: -0.9303 L23: 0.1177 REMARK 3 S TENSOR REMARK 3 S11: -0.0124 S12: -0.0398 S13: 0.2445 REMARK 3 S21: 0.0742 S22: 0.0423 S23: -0.0297 REMARK 3 S31: -0.0423 S32: -0.0669 S33: -0.0298 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: {A|663 - 794} REMARK 3 ORIGIN FOR THE GROUP (A): -12.8804 -32.0219 -10.7237 REMARK 3 T TENSOR REMARK 3 T11: -0.2154 T22: -0.0971 REMARK 3 T33: 0.0455 T12: -0.0543 REMARK 3 T13: 0.0333 T23: -0.0203 REMARK 3 L TENSOR REMARK 3 L11: 2.2481 L22: 2.8679 REMARK 3 L33: 4.7158 L12: 1.2030 REMARK 3 L13: -0.3271 L23: 0.4055 REMARK 3 S TENSOR REMARK 3 S11: 0.1783 S12: -0.5442 S13: -0.4054 REMARK 3 S21: 0.5442 S22: -0.2939 S23: 0.1994 REMARK 3 S31: 0.5442 S32: -0.3476 S33: 0.1156 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5AP4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-SEP-15. REMARK 100 THE DEPOSITION ID IS D_1290065029. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-MAY-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9173 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10484 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.850 REMARK 200 RESOLUTION RANGE LOW (A) : 59.860 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.85000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4C4J REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 38% (V/V) PEG300, PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 35.21000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 56.04000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 56.81500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 35.21000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 56.04000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 56.81500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 35.21000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 56.04000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 56.81500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 35.21000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 56.04000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 56.81500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 496 REMARK 465 HIS A 497 REMARK 465 HIS A 498 REMARK 465 HIS A 499 REMARK 465 HIS A 500 REMARK 465 HIS A 501 REMARK 465 HIS A 502 REMARK 465 SER A 503 REMARK 465 SER A 504 REMARK 465 GLY A 505 REMARK 465 VAL A 506 REMARK 465 ASP A 507 REMARK 465 LEU A 508 REMARK 465 GLY A 509 REMARK 465 THR A 510 REMARK 465 GLU A 511 REMARK 465 ASN A 512 REMARK 465 LEU A 513 REMARK 465 TYR A 514 REMARK 465 GLN A 670 REMARK 465 THR A 675 REMARK 465 THR A 676 REMARK 465 SER A 677 REMARK 465 VAL A 678 REMARK 465 VAL A 679 REMARK 465 LYS A 680 REMARK 465 ASP A 681 REMARK 465 SER A 682 REMARK 465 MET A 698 REMARK 465 SER A 699 REMARK 465 SER A 700 REMARK 465 SER A 701 REMARK 465 ARG A 702 REMARK 465 GLU A 703 REMARK 465 ASN A 704 REMARK 465 GLY A 705 REMARK 465 LYS A 706 REMARK 465 SER A 707 REMARK 465 LYS A 708 REMARK 465 SER A 709 REMARK 465 LYS A 710 REMARK 465 THR A 795 REMARK 465 HIS A 796 REMARK 465 PRO A 797 REMARK 465 VAL A 798 REMARK 465 ASN A 799 REMARK 465 GLN A 800 REMARK 465 MET A 801 REMARK 465 ALA A 802 REMARK 465 LYS A 803 REMARK 465 GLY A 804 REMARK 465 THR A 805 REMARK 465 THR A 806 REMARK 465 GLU A 807 REMARK 465 GLU A 808 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 515 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 523 CZ NH1 NH2 REMARK 470 ILE A 524 CG1 CG2 CD1 REMARK 470 LYS A 529 CG CD CE NZ REMARK 470 LYS A 538 CD CE NZ REMARK 470 LYS A 546 CG CD CE NZ REMARK 470 LYS A 547 CE NZ REMARK 470 GLU A 559 CG CD OE1 OE2 REMARK 470 ASN A 562 CG OD1 ND2 REMARK 470 GLN A 563 CG CD OE1 NE2 REMARK 470 LYS A 614 CG CD CE NZ REMARK 470 LYS A 615 CG CD CE NZ REMARK 470 LYS A 617 CG CD CE NZ REMARK 470 GLN A 672 CG CD OE1 NE2 REMARK 470 ASP A 674 CG OD1 OD2 REMARK 470 VAL A 684 CG1 CG2 REMARK 470 LYS A 696 CG CD CE NZ REMARK 470 ASP A 697 CG OD1 OD2 REMARK 470 ILE A 711 CG1 CG2 CD1 REMARK 470 LYS A 731 NZ REMARK 470 ILE A 738 CG1 CG2 CD1 REMARK 470 GLN A 740 CD OE1 NE2 REMARK 470 GLU A 753 CG CD OE1 OE2 REMARK 470 ASP A 758 CG OD1 OD2 REMARK 470 ILE A 759 CG1 CG2 CD1 REMARK 470 LYS A 762 CE NZ REMARK 470 LYS A 769 CG CD CE NZ REMARK 470 LYS A 773 CD CE NZ REMARK 470 LYS A 777 CG CD CE NZ REMARK 470 GLN A 778 CG CD OE1 NE2 REMARK 470 GLN A 794 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 647 NZ LYS A 649 1.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 578 7.68 -69.88 REMARK 500 SER A 646 -5.77 77.61 REMARK 500 LEU A 772 34.25 -89.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 7PE A 1796 REMARK 610 7PE A 1797 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE O38 A 1795 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7PE A 1796 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7PE A 1797 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1798 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1799 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5AP0 RELATED DB: PDB REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO REMARK 900 KINASE INHIBITOR DRUG RESISTANCE. REMARK 900 RELATED ID: 5AP1 RELATED DB: PDB REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO REMARK 900 KINASE INHIBITOR DRUG RESISTANCE. REMARK 900 RELATED ID: 5AP2 RELATED DB: PDB REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO REMARK 900 KINASE INHIBITOR DRUG RESISTANCE. REMARK 900 RELATED ID: 5AP3 RELATED DB: PDB REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO REMARK 900 KINASE INHIBITOR DRUG RESISTANCE. REMARK 900 RELATED ID: 5AP5 RELATED DB: PDB REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO REMARK 900 KINASE INHIBITOR DRUG RESISTANCE. REMARK 900 RELATED ID: 5AP6 RELATED DB: PDB REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO REMARK 900 KINASE INHIBITOR DRUG RESISTANCE. REMARK 900 RELATED ID: 5AP7 RELATED DB: PDB REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO REMARK 900 KINASE INHIBITOR DRUG RESISTANCE. REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE INCLUDING HEXAHISTIDINE TAG IS AS DESCRIBED REMARK 999 IN NAT. CHEM. BIOL. 2010, 6, 259-368 WITH AN ADDITIONAL REMARK 999 MUTATION S611G DBREF 5AP4 A 519 808 UNP P33981 TTK_HUMAN 519 808 SEQADV 5AP4 MET A 496 UNP P33981 EXPRESSION TAG SEQADV 5AP4 HIS A 497 UNP P33981 EXPRESSION TAG SEQADV 5AP4 HIS A 498 UNP P33981 EXPRESSION TAG SEQADV 5AP4 HIS A 499 UNP P33981 EXPRESSION TAG SEQADV 5AP4 HIS A 500 UNP P33981 EXPRESSION TAG SEQADV 5AP4 HIS A 501 UNP P33981 EXPRESSION TAG SEQADV 5AP4 HIS A 502 UNP P33981 EXPRESSION TAG SEQADV 5AP4 SER A 503 UNP P33981 EXPRESSION TAG SEQADV 5AP4 SER A 504 UNP P33981 EXPRESSION TAG SEQADV 5AP4 GLY A 505 UNP P33981 EXPRESSION TAG SEQADV 5AP4 VAL A 506 UNP P33981 EXPRESSION TAG SEQADV 5AP4 ASP A 507 UNP P33981 EXPRESSION TAG SEQADV 5AP4 LEU A 508 UNP P33981 EXPRESSION TAG SEQADV 5AP4 GLY A 509 UNP P33981 EXPRESSION TAG SEQADV 5AP4 THR A 510 UNP P33981 EXPRESSION TAG SEQADV 5AP4 GLU A 511 UNP P33981 EXPRESSION TAG SEQADV 5AP4 ASN A 512 UNP P33981 EXPRESSION TAG SEQADV 5AP4 LEU A 513 UNP P33981 EXPRESSION TAG SEQADV 5AP4 TYR A 514 UNP P33981 EXPRESSION TAG SEQADV 5AP4 PHE A 515 UNP P33981 EXPRESSION TAG SEQADV 5AP4 GLN A 516 UNP P33981 EXPRESSION TAG SEQADV 5AP4 SER A 517 UNP P33981 EXPRESSION TAG SEQADV 5AP4 MET A 518 UNP P33981 EXPRESSION TAG SEQADV 5AP4 GLY A 611 UNP P33981 SER 611 ENGINEERED MUTATION SEQRES 1 A 313 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 313 GLY THR GLU ASN LEU TYR PHE GLN SER MET SER VAL LYS SEQRES 3 A 313 GLY ARG ILE TYR SER ILE LEU LYS GLN ILE GLY SER GLY SEQRES 4 A 313 GLY SER SER LYS VAL PHE GLN VAL LEU ASN GLU LYS LYS SEQRES 5 A 313 GLN ILE TYR ALA ILE LYS TYR VAL ASN LEU GLU GLU ALA SEQRES 6 A 313 ASP ASN GLN THR LEU ASP SER TYR ARG ASN GLU ILE ALA SEQRES 7 A 313 TYR LEU ASN LYS LEU GLN GLN HIS SER ASP LYS ILE ILE SEQRES 8 A 313 ARG LEU TYR ASP TYR GLU ILE THR ASP GLN TYR ILE TYR SEQRES 9 A 313 MET VAL MET GLU CYS GLY ASN ILE ASP LEU ASN GLY TRP SEQRES 10 A 313 LEU LYS LYS LYS LYS SER ILE ASP PRO TRP GLU ARG LYS SEQRES 11 A 313 SER TYR TRP LYS ASN MET LEU GLU ALA VAL HIS THR ILE SEQRES 12 A 313 HIS GLN HIS GLY ILE VAL HIS SER ASP LEU LYS PRO ALA SEQRES 13 A 313 ASN PHE LEU ILE VAL ASP GLY MET LEU LYS LEU ILE ASP SEQRES 14 A 313 PHE GLY ILE ALA ASN GLN MET GLN PRO ASP THR THR SER SEQRES 15 A 313 VAL VAL LYS ASP SER GLN VAL GLY TPO VAL ASN TYR MET SEQRES 16 A 313 PRO PRO GLU ALA ILE LYS ASP MET SER SER SER ARG GLU SEQRES 17 A 313 ASN GLY LYS SER LYS SER LYS ILE SER PRO LYS SER ASP SEQRES 18 A 313 VAL TRP SER LEU GLY CYS ILE LEU TYR TYR MET THR TYR SEQRES 19 A 313 GLY LYS THR PRO PHE GLN GLN ILE ILE ASN GLN ILE SER SEQRES 20 A 313 LYS LEU HIS ALA ILE ILE ASP PRO ASN HIS GLU ILE GLU SEQRES 21 A 313 PHE PRO ASP ILE PRO GLU LYS ASP LEU GLN ASP VAL LEU SEQRES 22 A 313 LYS CYS CYS LEU LYS ARG ASP PRO LYS GLN ARG ILE SER SEQRES 23 A 313 ILE PRO GLU LEU LEU ALA HIS PRO TYR VAL GLN ILE GLN SEQRES 24 A 313 THR HIS PRO VAL ASN GLN MET ALA LYS GLY THR THR GLU SEQRES 25 A 313 GLU MODRES 5AP4 TPO A 686 THR PHOSPHOTHREONINE HET TPO A 686 11 HET O38 A1795 32 HET 7PE A1796 13 HET 7PE A1797 13 HET EDO A1798 4 HET EDO A1799 4 HETNAM TPO PHOSPHOTHREONINE HETNAM O38 6-{[3-(CYANOMETHOXY)-4-(1-METHYL-1H-PYRAZOL-4-YL) HETNAM 2 O38 PHENYL]AMINO}-2-(CYCLOHEXYLAMINO)PYRIDINE-3- HETNAM 3 O38 CARBONITRILE HETNAM 7PE 2-(2-(2-(2-(2-(2-ETHOXYETHOXY)ETHOXY)ETHOXY)ETHOXY) HETNAM 2 7PE ETHOXY)ETHANOL HETNAM EDO 1,2-ETHANEDIOL HETSYN TPO PHOSPHONOTHREONINE HETSYN 7PE POLYETHYLENE GLYCOL FRAGMENT HETSYN EDO ETHYLENE GLYCOL FORMUL 1 TPO C4 H10 N O6 P FORMUL 2 O38 C24 H25 N7 O FORMUL 3 7PE 2(C14 H30 O7) FORMUL 5 EDO 2(C2 H6 O2) FORMUL 7 HOH *20(H2 O) HELIX 1 1 ASP A 561 SER A 582 1 22 HELIX 2 2 LEU A 609 LYS A 616 1 8 HELIX 3 3 ASP A 620 GLN A 640 1 21 HELIX 4 4 LYS A 649 ALA A 651 5 3 HELIX 5 5 PRO A 691 ASP A 697 1 7 HELIX 6 6 SER A 712 GLY A 730 1 19 HELIX 7 7 ASN A 739 ASP A 749 1 11 HELIX 8 8 GLU A 761 LEU A 772 1 12 HELIX 9 9 ASP A 775 ARG A 779 5 5 HELIX 10 10 SER A 781 LEU A 786 1 6 HELIX 11 11 HIS A 788 ILE A 793 1 6 SHEET 1 AA 6 SER A 517 VAL A 520 0 SHEET 2 AA 6 ARG A 523 GLY A 534 -1 O ARG A 523 N VAL A 520 SHEET 3 AA 6 SER A 537 ASN A 544 -1 O SER A 537 N GLY A 534 SHEET 4 AA 6 ILE A 549 ASN A 556 -1 O TYR A 550 N VAL A 542 SHEET 5 AA 6 TYR A 597 GLU A 603 -1 O ILE A 598 N VAL A 555 SHEET 6 AA 6 LEU A 588 ILE A 593 -1 N TYR A 589 O VAL A 601 SHEET 1 AB 3 ILE A 607 ASP A 608 0 SHEET 2 AB 3 PHE A 653 VAL A 656 -1 N ILE A 655 O ILE A 607 SHEET 3 AB 3 MET A 659 LEU A 662 -1 O MET A 659 N VAL A 656 LINK C GLY A 685 N TPO A 686 1555 1555 1.34 LINK C TPO A 686 N VAL A 687 1555 1555 1.34 SITE 1 AC1 13 ILE A 531 GLN A 541 ALA A 551 ILE A 586 SITE 2 AC1 13 CYS A 604 GLY A 605 ASN A 606 ILE A 607 SITE 3 AC1 13 ASP A 608 LEU A 654 ILE A 663 MET A 671 SITE 4 AC1 13 7PE A1796 SITE 1 AC2 9 LYS A 553 VAL A 555 TYR A 568 GLU A 571 SITE 2 AC2 9 MET A 600 ILE A 663 ASP A 664 MET A 671 SITE 3 AC2 9 O38 A1795 SITE 1 AC3 7 TRP A 622 LYS A 625 SER A 626 LYS A 629 SITE 2 AC3 7 VAL A 791 ILE A 793 GLN A 794 SITE 1 AC4 5 ILE A 549 TYR A 550 TYR A 589 GLU A 603 SITE 2 AC4 5 CYS A 604 SITE 1 AC5 4 HIS A 639 PRO A 713 ILE A 782 PRO A 783 CRYST1 70.420 112.080 113.630 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014201 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008922 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008800 0.00000